Evaluation of anti-allergic properties of caffeic acid phenethyl ester in a murine model of systemic anaphylaxis

Toxicology and Applied Pharmacology

Volumn 226, Issue 1, 2008, Pages 22-29

  Park, Sae Gwang ^a   Lee, Da Young ^a   Seo, Su Kil ^a   Lee, Soo Woong ^a   Kim, Se Kwon ^b   Jung, Won Kyo ^b   Kang, Mi Seon ^c   Choi, Yung Hyun ^d   Yea, Sung Su ^e   Choi, Inhak ^a   Choi, Il Whan ^a  

^a Department of Microbiology   (South Korea)

^b Pukyong National University   (South Korea)

^c Inje University   (South Korea)

^d Dong Eui University   (South Korea)

^e Inje University College of Medicine   (South Korea)

Author keywords

Anaphylaxis; Caffeic acid phenethyl ester; Histamine; IgE; NF B; TNF

Indexed keywords

CAFFEIC ACID PHENETHYL ESTER; DEXAMETHASONE; HISTAMINE; IMMUNOGLOBULIN E; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; OVALBUMIN; PROPOLIS; THROMBOCYTE ACTIVATING FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ANAPHYLAXIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBACTERIAL ACTIVITY; ANTIFUNGAL ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; FEMALE; HEMOCONCENTRATION; HISTAMINE BLOOD LEVEL; HISTAMINE RELEASE; HISTOPATHOLOGY; IMMUNOGLOBULIN PRODUCTION; IMMUNOMODULATION; KIDNEY HEMORRHAGE; KIDNEY MEDULLA; LUNG EDEMA; MOUSE; NONHUMAN;

ANAPHYLAXIS; ANIMALS; ANTI-ALLERGIC AGENTS; CAFFEIC ACIDS; DISEASE MODELS, ANIMAL; FEMALE; HISTAMINE RELEASE; IMMUNOGLOBULIN E; MICE; MICE, INBRED ICR; NF-KAPPA B; OVALBUMIN; PHENYLETHYL ALCOHOL; TUMOR NECROSIS FACTOR-ALPHA;

APIS MELLIFERA; BACTERIA (MICROORGANISMS); MURINAE; MUS;

EID: 36849077680     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2007.08.003     Document Type: Article

References (49)

1. Azzolina A., Bongiovanni A., and Lampiasi N. Substance P induces TNF-alpha and IL-6 production through NF-kappaB in peritoneal mast cells. Biochim. Biophys. Acta 1643 (2003) 75-83
2. Auphan N., Didonato J.A., Rosette C., Helmberg A., and Karin M. Immunosuppression by glucocorticoids: inhibition of NF-κB activity through induction of I O B synthesis. Science 270 (1995) 286-290
3. Baldwin Jr. A.S. The NF-kappaB and I-kappaB proteins: new discoveries and insights. Annu. Rev. Immunol. 14 (1996) 649-683
4. Barnes P.J., and Karin M. Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N. Engl. J. Med. 336 (1997) 1066-1071
5. Braquet P., Touqui L., Shen T.Y., and Vargaftig B.B. Perspectives in platelet-activating factor research. Pharmacol. Rev. 39 (1987) 97-145
6. Brzezinska-Blaszczyk E., and Pietrzak A. Tumor necrosis factor (TNF-α) activates human adenoidal and cutaneous mast cells to histamine secretion. Immunol. Lett. 59 (1997) 139-143
7. Choi I.H., Ha T.Y., Lee D.G., Park J.S., Lee J.H., Park Y.M., and Lee H.K. Occurrence of disseminated intravascular coagulation (DIC) in active systemic anaphylaxis: role of platelet-activating factor. Clin. Exp. Immunol. 100 (1995) 390-394
8. Choi I.H., Shin Y.M., Park J.S., Lee M.S., Han E.H., Chai O.H., Im S.Y., Ha T.Y., and Lee H.K. Immunoglobulin E-dependent active fatal anaphylaxis in mast cell-deficient mice. J. Exp. Med. 188 (1998) 1587-1592
9. Choi J.H., Ko H.M., Kim J.W., Lee H.K., Han S.S., Chun S.B., and Im S.Y. Platelet-activating factor-induced early activation of NF-κB plays a crucial role for organ clearance of Candida albicans. J. Immunol. 166 (2001) 5139-5144
10. Choi I.W., Kim Y.S., Kim D.K., Choi J.H., Seo K.H., Im S.Y., Kwon K.S., Lee M.S., Ha T.Y., and Lee H.K. Platelet-activating factor-mediated NF-κB dependency of a late anaphylactic reaction. J. Exp. Med. 198 (2003) 145-151
11. Donovan C.E., Mark D.A., He H.Z., Liou H.C., Kobzik L., Wang Y., De Sanctis G.T., Perkins D.L., and Finn P.W. NF-κB/Rel transcription factor: c-Rel promotes airway hyperresponsiveness and allergic pulmonary inflammation. J. Immunol. 163 (1999) 6827-6833
12. Fesen M.R., Kohn K.W., Leteurtre F., and Pommier Y. Inhibitors of human immunodeficiency virus integrase. Proc. Natl. Acad. Sci. U. S. A. 90 (1993) 2399-2403
13. Fukuda A.I., and Breuel K.F. Effect of platelet activating factor on embryonic development and implantation in the mouse. Hum. Reprod. 11 (1996) 2746-2749
14. Ghosh S., May M.J., and Kopp E.B. NF-κB and Rel proteins: evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol. 16 (1998) 225-260
15. Ko H.M., Seo K.H., Han S.J., Ahn K.Y., Choi I.H., Koh G.Y., Lee H.K., Ra M.S., and Im S.Y. NF-κB-dependency of platelet-activating factor-induced angiogenesis. Cancer Res. 62 (2002) 1809-1814
16. Gordon J.R., and Galli S.J. Release of both preformed and newly synthesized tumor necrosis factor alpha (TNF-alpha)/cachectin by mouse mast cells stimulated via the Fc epsilon RI: a mechanism for the sustained action of mast cell-derived TNF-alpha during IgE-dependent biological responses. J. Exp. Med. 174 (1991) 103-107
17. Hayglass K.T., and Stefura W.P. Antigen-specific inhibition of ongoing murine IgE responses. II. Inhibition of IgE responses induced by treatment with glutaraldehyde-modified allergens is paralleled by reciprocal increases in IgG2a synthesis. J. Immunol. 147 (1991) 2455-2460
18. Ha T.Y., and Reed N.D. Immune response potential of mast cell-deficient mice W/Wv mice. Int. Arch. Allergy Appl. Immunol. 80 (1986) 85-94
19. Han S.J., Choi J.H., Ko H.M., Yang H.W., Choi I.W., Lee H.K., Lee O.H., and Im S.Y. Glucocorticoids prevent NF-κB activation by inhibiting the early release of platelet-activating factor in response to lipopolysaccharide. Eur. J. Immunol. 29 (1999) 1334-1341
20. Hepsen I.F., Er H., and Cekic O. Topically applied water extract of propolis of to suppress corneal neovascularization in rabbits. Ophthalmic Res. 31 (1999) 426-431
21. Hishikawa K., Nakaki T., and Fujita T. Oral flavonoid supplementation attenuates atherosclerosis development in apolipoprotein E-deficient mice. Arterioscler. Thromb. Vasc. Biol. 25 (2005) 442-446
22. Hughes J.M., Stringer R.S., Black J.L., and Armour C.L. The effects of tumor-necrosis-factor on mediator release from human lung. Pulm. Pharmacol. 8 (1995) 31-36
23. Ilhan A., Iraz M., Gurel A., Armutcu F., and Akyol O. Caffeic acid phenethyl ester exerts a neuroprotective effect on CNS against pentylenetetrazol-induced seizures in mice. Neurochem. Res. 29 (2004) 2287-2292
24. Im S.Y., Ko H.M., Kim J.W., Lee H.K., Ha T.Y., Lee H.B., Oh S.J., Bai S., Chung K.C., Lee Y.B., Kang H.S., and Chun S.B. Augmentation of tumor metastasis by platelet-activating factor. Cancer Res. 56 (1996) 2662-2665
25. Im S.Y., Han S.J., Ko H.M., Choi J.H., Chun S.B., Lee D.G., Ha T.Y., and Lee H.K. Involvement of nuclear factor-κB in platelet-activating factor-mediated tumor necrosis factor-alpha expression. Eur. J. Immunol. 27 (1997) 2800-2804
26. Ishizaka T., and Ishizaka K. Biology of immunoglobulin E. Molecular basis of reaginic hypersensitivity. Prog. Allergy 19 (1975) 60-121
27. Kopp E.B., and Ghosh S. NF-κB and Rel proteins in innate immunity. Adv. Immunol. 58 (1995) 1-27
28. Koshihara Y., Neichi T., Murota S., Lao A., Fujimoto Y., and Tatsuno T. Caffeic acid is a selective inhibitor for leukotriene biosynthesis. Biochim. Biophys. Acta 792 (1984) 92-97
29. Lee W.Y., and Sehon A.H. Abrogation of reaginic antibodies with modified allergens. Nature 267 (1977) 618-619
30. Liao H.F., Chen Y.Y., Liu J.J., Hsu M.L., Shieh H.J., Liao H.J., Shieh C.J., Shiao M.S., and Chen Y.J. Inhibitory effect of caffeic acid phenethyl ester on angiogenesis, tumor invasion, and metastasis. J. Agric. Food Chem. 51 (2003) 7907-7912
31. Marshall J.S., and Bell E.B. Induction of an auto-anti-IgE response in rats. III. Inhibition of a specific IgE response. Immunology 66 (1989) 428-433
32. Marquardt D.L., and Walker L.L. Dependence of mast cell IgE-mediated cytokine production on nuclear factor-B activity. J. Allergy Clin. Immunol. 105 (2000) 500-505
33. Mican J.A., Arora N., Burd P.R., and Metcalfe D.D. Passive cutaneous anaphylaxis in mouse skin is associated with local accumulation of interleukin-6 mRNA and immunoreactive interleukin-6 protein. J. Allergy Clin. Immunol. 90 (1992) 815-824
34. Michaluart P., Masferrer J.L., Carothers A.M., Subbaramaiah K., Zweifel B.S., Koboldt C., Mestre J.R., Grunberger D., Sacks P.G., Tanabe T., and Dannenberg A.J. Inhibitory effects of caffeic acid phenethyl ester on the activity and expression of cyclooxygenase-2 in human oral epithelial cells and in a rat model of inflammation. Cancer Res. 59 (1999) 2347-2352
35. Montrucchio G., Lupia E., Battaglia E., Passerini G., Bussolino F., Emanuelli G., and Camussi G. Tumor necrosis factor-α-induced angiogenesis depends on in situ platelet-activating factor biosynthesis. J. Exp. Med. 180 (1994) 377-382
36. Munoz J., and Bergman R.K. Mechanism of anaphylactic death in the mouse. Nature 205 (1965) 199-200
37. Natarajan K., Singh S., Burke Jr. T.R., Grunberger D., and Aggarwal B.B. Caffeic acid phenethyl ester is a potent and specific inhibitor of activation of nuclear transcription factor NF-kappa B. Proc. Natl. Acad. Sci. U. S. A. 93 (1996) 9090-9095
38. Okudaira H., Sakurai Y., Terada K., Terada E., Ogita T., and Miyamoto T. Cyclosporin A-induced suppression of ongoing IgE antibody formation in the mouse. Int. Arch. Allergy Appl. Immunol. 79 (1986) 164-168
39. Orban Z., Mitsiades N., Burke Jr. T.R., Tsokos M., and Chrousos G.P. Caffeic acid phenethyl ester induces leukocyte apoptosis, modulates nuclear factor-kappa B and suppresses acute inflammation. Neuroimmunomodulation 7 (2000) 99-105
40. Orsolic N., Terzic S., Mihaljevic Z., Sver L., and Basic I. Effects of local administration of propolis and its polyphenolic compounds on tumor formation and growth. Biol. Pharm. Bull. 28 (2005) 1928-1933
41. Park E.H., and Kang J.H. Suppressive effects of propolis in rat adjuvant arthritis. Arch. Pharm. Res. 22 (1999) 554-558
42. Paul W.E., Seder R.A., and Plaut M. Lymphokine and cytokine production by Fc RI+ cells. Adv. Immunol. 53 (1993) 1-29
43. Pelletier C., Varin-Blank N., Rivera J., Iannascoli B., Marchand F., David B., Weyer A., and Blank U. FcεRI-mediated induction of TNF-α gene expression in the RBL-2H3 mast cell line: regulation by a novel NF-κB-like nuclear binding complex. J. Immunol. 161 (1998) 4768-4776
44. Saxon A., Beall G.N., Rohr A.S., and Adelman D.C. Immediate hypersensitivity reactions to beta-lactam antibiotics. Ann. Intern. Med. 107 (1987) 204-215
45. Scheinman R.I., Cogswell P.C., Lofquist A.K., and Baldwin Jr. A.S. Role of transcriptional activation of I O B § in mediation of immunosuppression by glucocorticoids. Science 270 (1995) 283-286
46. Snapper C.M., Zelazowski P., Rosas F.R., Kehry M.R., Tian M., Baltimore D., and Sha W.C. B cells from p50/NF-kappa B knockout mice have selective defects in proliferation, differentiation, germ-line CH transcription, and Ig class switching. J. Immunol. 156 (1996) 183-191
47. Van Overveld F.J., Jorens P.G., Rampart M., De Backer W., and Vermeire P.A. Tumour necrosis factor stimulates human skin mast cells to release histamine and tryptase. Clin. Exp. Allergy 21 (1991) 711-714
48. Vilain B., Lagente V., Touvay C., Desquand S., Randon J., Lefort J., Braquet P., and Vargaftig B.B. Pharmacological control of the in vivo passive anaphylactic shock by the PAF-acether antagonist compound BN 52021. Pharmacol. Res. Commun. 18, Suppl: (1986) 119-126
49. Wershil B.K., Wang Z.S., Gordon J.R., and Galli S.J. Recruitment of neutrophils during IgE-dependent cutaneous late phase reactions in the mouse is mast cell-dependent: partial inhibition of the reaction with antiserum against tumor necrosis factor-α. J. Clin. Invest. 87 (1991) 446-453